194 related articles for article (PubMed ID: 25641469)
21. Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer : A single institution, prospective study.
Jorgo K; Ágoston P; Major T; Takácsi-Nagy Z; Polgár C
Strahlenther Onkol; 2017 Jun; 193(6):452-458. PubMed ID: 28154882
[TBL] [Abstract][Full Text] [Related]
22. Five-year follow-up using a prostate stent as fiducial in image-guided radiotherapy of prostate cancer.
Carl J; Sander L
Acta Oncol; 2015 Jun; 54(6):862-7. PubMed ID: 25539443
[TBL] [Abstract][Full Text] [Related]
23. [Intraprostatic calcifications as natural fiducial markers in image-guided radiotherapy for prostate cancer].
Sbai A; Thariat J; Tachfouti N; Pan Q; Lagrange JL
Cancer Radiother; 2014 Dec; 18(8):740-4. PubMed ID: 25451671
[TBL] [Abstract][Full Text] [Related]
24. Infection after prostatic transrectal fiducial marker implantation for image guided radiation therapy.
Reynaud T; Ben Aicha I; Carignan D; Pelchat C; Fiset C; Foster W; Martin AG; Vigneault E
Cancer Radiother; 2023 May; 27(3):214-218. PubMed ID: 37080858
[TBL] [Abstract][Full Text] [Related]
25. Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.
Vesprini D; Catton C; Jacks L; Lockwood G; Rosewall T; Bayley A; Chung P; Gospodarowicz M; Ménard C; Milosevic M; Nichol A; Skala M; Warde P; Bristow RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):608-16. PubMed ID: 22099034
[TBL] [Abstract][Full Text] [Related]
26. Effect of rectal enema on intrafraction prostate movement during image-guided radiotherapy.
Choi Y; Kwak DW; Lee HS; Hur WJ; Cho WY; Sung GT; Kim TH; Kim SD; Yun SG
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):236-42. PubMed ID: 25229723
[TBL] [Abstract][Full Text] [Related]
27. Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?
Loh J; Baker K; Sridharan S; Greer P; Wratten C; Capp A; Gallagher S; Martin J
Radiat Oncol; 2015 Feb; 10():38. PubMed ID: 25890179
[TBL] [Abstract][Full Text] [Related]
28. First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
Deutschmann H; Kametriser G; Steininger P; Scherer P; Schöller H; Gaisberger C; Mooslechner M; Mitterlechner B; Weichenberger H; Fastner G; Wurstbauer K; Jeschke S; Forstner R; Sedlmayer F
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1624-32. PubMed ID: 22209149
[TBL] [Abstract][Full Text] [Related]
29. Image-guided radiation therapy for prostate cancer: A computed tomography-based assessment of fiducial marker migration between placement and 7 days.
Kumar KA; Wu T; Tonlaar N; Stepaniak C; Yenice KM; Liauw SL
Pract Radiat Oncol; 2015; 5(4):241-7. PubMed ID: 25543198
[TBL] [Abstract][Full Text] [Related]
30. Vector analysis of prostate patient setup with image-guided radiation therapy via kV cone beam computed tomography.
Perks J; Turnbull H; Liu T; Purdy J; Valicenti R
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):915-9. PubMed ID: 20643510
[TBL] [Abstract][Full Text] [Related]
31. Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence.
Park SS; Yan D; McGrath S; Dilworth JT; Liang J; Ye H; Krauss DJ; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):947-52. PubMed ID: 22208964
[TBL] [Abstract][Full Text] [Related]
32. EUS-guided fiducial placement before targeted radiation therapy for prostate cancer.
Yang J; Abdel-Wahab M; Ribeiro A
Gastrointest Endosc; 2009 Sep; 70(3):579-83. PubMed ID: 19560140
[TBL] [Abstract][Full Text] [Related]
33. Long-term clinical outcomes of lipiodol marking using standard gastroscopy for image-guided radiotherapy of upper gastrointestinal cancers.
Be KH; Khor R; Lim Joon D; Starvaggi B; Chao M; Ng SP; Ng M; Zorron Cheng Tao Pu L; Efthymiou M; Vaughan R; Chandran S
World J Gastroenterol; 2021 Nov; 27(42):7387-7401. PubMed ID: 34876797
[TBL] [Abstract][Full Text] [Related]
34. Transperineal implantation of gold fiducial markers (gold seeds) for prostate image-guided radiation therapy: a feasible technique associated with a low risk of complications.
Saad A; Goldstein J; Lawrence YR; Weiss I; Saad R; Spieler B; Symon Z
J Med Radiat Sci; 2015 Dec; 62(4):261-6. PubMed ID: 27512572
[TBL] [Abstract][Full Text] [Related]
35. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT).
Barney BM; Lee RJ; Handrahan D; Welsh KT; Cook JT; Sause WT
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):301-5. PubMed ID: 20864274
[TBL] [Abstract][Full Text] [Related]
36. Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation.
Jereczek-Fossa BA; Zerini D; Fodor C; Santoro L; Cambria R; Garibaldi C; Tagaste B; Vavassori A; Cattani F; Alterio D; Gherardi F; Serafini F; Rocco B; Musi G; De Cobelli O; Orecchia R
Urol Oncol; 2011; 29(5):523-32. PubMed ID: 20005749
[TBL] [Abstract][Full Text] [Related]
37. Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer.
Chu W; Loblaw DA; Chan K; Morton G; Choo R; Szumacher E; Danjoux C; Pignol JP; Cheung P
Radiat Oncol; 2015 Apr; 10():95. PubMed ID: 25903934
[TBL] [Abstract][Full Text] [Related]
38. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
[TBL] [Abstract][Full Text] [Related]
39. [Patient positioning using in-room kV CT for image-guided radiotherapy (IGRT) of prostate cancer].
Kliton J; Agoston P; Major T; Polgár C
Magy Onkol; 2012 Sep; 56(3):193-8. PubMed ID: 23008828
[TBL] [Abstract][Full Text] [Related]
40. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
